Q2 2023 Oncopeptides AB Earnings Call Transcript
Welcome to the Oncopeptides Q2 Earnings Call. (Operator Instructions) Now I will hand the conference over to CEO, Sofia Heigis; and CFO, Holger Lembrér. Please go ahead.
()-
Hi, everyone and a warm welcome to the Oncopeptides presentation for investors and media of our report for the second quarter. These are the standard disclaimers. My name Sofia Heigis. And on the call, I have our CFO, Holger Lembrér. After my introduction, Holger will give you the financial summary for the second quarter, followed by a commercial update by myself.
While I have been the CFO of the company less than a week, I have been with the company for more than 3 years and focused the last year to lead the commercialization of Pepaxti. I therefore believe that the runway into my new role will be short. I am both humbled and excited about my new role, but I am also full of confidence for 2 reasons. I know the Oncopeptides organization, the competencies, the mindset, the engagement and the drive. I feel
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
